CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Cholesterol-Lowering Agents A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Association Between Living in Food Deserts and Cardiovascular Risk Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents Advances in Coronary No-Reflow Phenomenon-a Contemporary Review

Original Research2020 Nov, 76 (19) 2197–2207.

JOURNAL:J Am Coll Cardiol. Article Link

Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization

ME Farkouh , LC Godoy, V Fuster et al. Keywords: diabetes; coronary revascularization; LDL-Cholesterol

Full Text PDF